DOCSLIB.ORG

Life Sciences in Israel

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Life Sciences in Israel Inspiration Invention Innovation Life Sciences in Israel www.investinisrael.gov.il Life Sciences in Israel Table of Contents Israel: A Powerhouse of Opportunities Israel: A Powerhouse of Opportunities .................................................3 Over the last decade, Israel has introduced a wealth of groundbreaking Why Israel’s Life Sciences? and valuable innovations in life sciences. Israel’s life sciences sector is Israel’s Life Science Sectors ..................................................................4 supported by a strong foundation of academic excellence, including some Over 1,000 life sciences Medical Devices of the world’s leading research institutes, renowned R&D facilities and companies - biopharma and Biopharmaceuticals cutting-edge medical centers. Bolstered by a highly skilled workforce, a medical devices Healthcare IT flourishing high-tech environment, and an entrepreneurial spirit, Israeli companies have been joined by leading multinationals in making Israel a Over 1/3 of LS Start-Ups Israel’s Biomedical Engineering: recognized force in the industry worldwide. Global giants, including Johnson already generate revenue. Spotlight on Stem Cell Research .........................................................11 & Johnson, Perrigo, GE Healthcare, Phillips Medical, Abbott Laboratories, Source of numerous Merck Serono and Sanofi together with local companies such as Teva, itself blockbuster drugs such Israel’s Life Sciences Competitive Edge ..............................................15 a multinational company, Given Imaging, InSightec, Medinol and others as Copaxone and Rebif have been continuously developing and marketing life-changing medical generating over $5B in Government Support ...........................................................................19 breakthroughs and innovations. annual sales Prior to 1996, Israel was home to 186 life sciences companies. By 2012, First in the world in quality of this number had passed 1,000. With some 40 new companies formed scientific research institutions each year, 41% of all life sciences companies operating in Israel today (World Economic Forum [WEF] were established during the last ten years. In a relatively short period 2011-12) of time, an impressive 34% of these companies have already begun to First in the world for medical generate revenue, demonstrating that Israel has crossed the threshold device patents per capita, 4th from an attractive start-up arena to a source of advanced, commercially for bio-pharma (US Patent viable and promising businesses. The bridge connecting excellent science Office 2009) to revenue-generating companies has been established. As proof of the Israel is 4th in global scientific industry’s development, in 2011 life sciences exports reached $8.9 billion, activity, ranking just behind an increase of 10% over 2010. A rich pipeline of seed companies promises Switzerland, Sweden and to perpetuate current growth. Denmark for the number of scientific publications per citizen (Council for Higher Education). Pioneers in stem cell research Four Israeli academics have won the Nobel Prize and therapeutics in Chemistry. Professor Daniel Shechtman Extensive international R&D of the Technion-Israel Institute of Technology and commercial partnerships received the Nobel Prize in 2010 for his discovery of quasicrystals, a new form of matter that has World-renowned academic become a major subject field for scientists, mathematicians and research institutes such as the Technion and the Weizmann crystallographers. Professor Ada Yonath of the Weizmann Institute Institute received the Nobel Prize in 2009 for showing how ribosomes function, and Aaron Ciechanover and Avram Hershko of the Technion received Unique financing tools and the Nobel Prize for Chemistry in 2004 for their discovery of Ubiquitin- incubator frameworks for mediated protein degradation, leading to breakthroughs in the start-ups understanding and treatment of diseases such as cancer, Alzheimer’s, Parkinson’s disease and cystic fibrosis. 2 Life Sciences in Israel Israeli Life Sciences Sectors Today, Israel is home to a thriving life sciences industry in which the major The closed cell stent design which facilitates blood flow to the heart sectors are medical devices and biopharma. Over the last five years, more was pioneered and developed by Medinol in the early 1990s. Medinol companies were established in life sciences than in any other area, with the continues to introduce additional innovations in the field of heart NESS Neuromuscular Israel’s Life Science rate of investments (including corporate funds, venture capital and angel catheterization. Electrical Stimulation Industry - Sectors investors) outpacing other segments of the economy. Systems was awarded (1000 companies) A highly advanced and cost- efficient surgical sealant, or “biological glue”, the Medical Design Quixil, which facilitates haemostasis and reduces operative and post- Excellence Award (Medical AGBiotech Medical Devices operative bleeding, was developed by Omrix Biopharmaceuticals, which Device and Diagnostic Industry 2% Healthcare IT was acquired for $438m by Ethicon, a Johnson & Johnson company. magazine) for its L300 leg Pharmaceuticals 8% Other In the area of medical devices, Israel’s scientists and engineers have 11% 4% integrated advanced technologies in electronics, communications, and ExAblate 2000, a non-invasive surgery developed by InSightec which neuroprosthesis, a noninvasive electro-optics in the development of world-class innovations in digital uses MR guided Focused Ultrasound to treat uterine fibroids. device which delivers electrical imaging, medical lasers, electro-medical devices, telemedicine, surgical stimulation to nerves and muscles Argo Medical Technologies Ltd has developed a restoration device equipment, diagnostic kits and rehabilitation equipment. According in the leg, improving the walking for people with lower limb disabilities. The company’s flagship ReWalk to the US Patent and Trademark Office, Israel has the highest rate of ability of those suffering from product offers an ambulation alternative to wheelchair users, enabling registered medical device patents per capita in the world, with cutting- foot drop associated with central paralyzed people to stand, walk and even climb stairs. nervous system injury or disease. Biotechnology edge innovations such as ingestible cameras, portable cardiac ultrasound 18% systems, implantable visual aids for the sight-impaired and instant CT Medical Devices scanners helping to significantly improve global health, and well-being, Cutting Edge R&D: Medical Devices 57% while at the same time, creating significant investor value. A treatment using an instrument to determine the patient’s liver Source: IVC Database 2012 The largest subsector in the medical device arena is therapeutic devices, function has been introduced by Exalenz. The device has already been both implantable and disposable. successfully tested on hepatitis C and NAFLD (non-alcoholic fatty liver disease) patients and is expected to be on the market soon. Many of Israel’s trailblazing medical devices have already been adopted worldwide and are generating substantial revenues. Others have been Microneedle based systems for the painless intradermal delivery of Israel’s Medical Device introduced more recently and are undergoing clinical trials both in Israel drugs were implemented by NanoPass. NanoPass collaborated with Companies - Subsectors and other countries. GlaxoSmithKline on optimization of its platform for vaccine delivery. (448 companies) Ventor, acquired by Medtronic in 2009 for $325m, created a unique aortic Drug Delivery Innovative Medical Devices valve prosthesis which can be implanted “off pump” on a beating heart. Monitoring Other 5% Ventor’s unique valve design allows for easy implantation, enhanced Imaging 7% 3% The Pillcam, the first miniature ingested camera which diagnoses and prosthesis anchoring and superior hemodynamic performance. 10% photographs abnormalities in the gastrointestinal tract, was introduced by Given Imaging (NASDAQ: GIVN). Given Imaging continues to be The NovoTTF, a portable, wearable device that delivers an anti-mitotic, successful, posting profits of $181 million in 2011. anti-cancer therapy as patients maintain their normal activities, was developed by Novocure. In 2011, it obtained FDA approval for its use in The superDimension i•Logic System, acquired by Covidien in 2012 the treatment of adults whose brain tumors recurred after chemotherapy. for $350m, uses Electromagnetic Navigation Bronchoscopy (ENB) to Diagnostic provide minimally invasive access to lesions deep in the lungs as well as The SMT filter is a proprietary medical device that acts as a filter, 14% Disposable & Implantable mediastinal lymph nodes, enabling physicians to diagnose benign and allowing normal blood flow to the brain, by filtering and diverting all 43% Medical Equipment malignant lung lesions and avoid the need for higher-risk procedures. emboli downstream, thus preventing stroke. The product is designed to 18% be used during interventional and surgical procedures. Disc-O-Tech Medical Technologies develops expandable implants used Source: Israel Life Sciences in minimally invasive orthopedic surgeries. The company has developed Industry (ILSI) 2010 an expandable spinal implant system for use in lumbar spinal fusion procedures and offers a wide range of special fixation nails and pins for complicated fractures. 4 5 Life Sciences in Israel Ear infection
Load more

Recommended publications
  • List of Section 13F Securities
    List of Section 13F Securities 1st Quarter FY 2004 Copyright (c) 2004 American Bankers Association. CUSIP Numbers and descriptions are used with permission by Standard & Poors CUSIP Service Bureau, a division of The McGraw-Hill Companies, Inc. All rights reserved. No redistribution without permission from Standard & Poors CUSIP Service Bureau. Standard & Poors CUSIP Service Bureau does not guarantee the accuracy or completeness of the CUSIP Numbers and standard descriptions included herein and neither the American Bankers Association nor Standard & Poor's CUSIP Service Bureau shall be responsible for any errors, omissions or damages arising out of the use of such information. U.S. Securities and Exchange Commission OFFICIAL LIST OF SECTION 13(f) SECURITIES USER INFORMATION SHEET General This list of “Section 13(f) securities” as defined by Rule 13f-1(c) [17 CFR 240.13f-1(c)] is made available to the public pursuant to Section13 (f) (3) of the Securities Exchange Act of 1934 [15 USC 78m(f) (3)]. It is made available for use in the preparation of reports filed with the Securities and Exhange Commission pursuant to Rule 13f-1 [17 CFR 240.13f-1] under Section 13(f) of the Securities Exchange Act of 1934. An updated list is published on a quarterly basis. This list is current as of March 15, 2004, and may be relied on by institutional investment managers filing Form 13F reports for the calendar quarter ending March 31, 2004. Institutional investment managers should report holdings--number of shares and fair market value--as of the last day of the calendar quarter as required by Section 13(f)(1) and Rule 13f-1 thereunder.
    [Show full text]
  • Life Sciences in Israel
    STATE OF ISRAEL Ministry of Industry Trade and Labor Investment Promotion Center Inspiration Invention Innovation Life Sciences in Israel www.investinisrael.gov.il Table of Contents .......................................... 3 Israel: A Powerhouse of Opportunities ............................................................ 3 Israel’s Life Science Sectors Medical Devices ........................................................................ 4 Healthcare IT ............................................................................ 4 BioPharmaceutical .................................................................... 7 Israel’s Biomedical Engineering - ................................................... 11 Spotlight on Stem Cell Research ....................................... 15 Israel’s Life Sciences Competitive Edge ..................................................................... 19 Government Support 2 Life Sciences in Israel Israel: A Powerhouse of Opportunities Why Israel’s Life Sciences Over the last decade, Israel has introduced a wealth of groundbreaking More than 1,000 Life and valuable innovations in Life Sciences. Israel’s Life Sciences sector Sciences Companies - is supported by a strong foundation of academic excellence, including Biopharma and Medical some of the world’s leading research institutes, renowned R&D Devices facilities and cutting-edge medical centers. Bolstered by a highly skilled Over 1/3 of LS Start-Ups workforce, a flourishing high-tech environment, and an entrepreneurial already generate revenue
    [Show full text]
  • Accelerating Medical Solutions in Israel: Building a Global Life Science Industry
    Volume 6 May 2008 May Financial Innovations Lab Report Lab Innovations Financial Accelerating Medical Solutions in Israel: Building a Global Life Science Industry FINANCIAL INNOVATIONS LAB REPORT Volume 6 May 2008 May Financial Innovations Lab Report Lab Innovations Financial Accelerating Medical Solutions in Israel: Building a Global Life Science Industry FINANCIAL INNOVATIONS LAB REPORT Acknowledgments This "Financial Innovations Lab Report for Accelerating The Israel Presidential Conference "Facing Tomorrow" will Medical Solutions in Israel: Building a Global Life Science be dedicating a special session to the translation of medical Industry" was prepared by Glenn Yago, Ronit Purian-Lukatch innovation in Israel into business success, based on the and Ilan Vaknin. Liza Ireni-Saban drafted Appendix 1 on current report. We thank President Shimon Peres for his regulation and legislation concerning clinical and genetic vision and inspiration of the process whereby the Financial trials. We are grateful to all participants of the Financial Innovations Lab took place. Innovations Lab and workgroups for their contributions to the ideas summarized in this report. A list of participants may be found in Appendix 2. We give special thanks to the Sacta-Rashi Fund and the Yeshaya Horowitz Foundation for their interest and continuing support of this work. The Milken Institute is an independent economic think tank whose mission is to improve the lives and economic conditions of diverse populations in the US and around the world by helping business
    [Show full text]
  • Life Sciences Overview 2008.FH11
    STATE OF ISRAEL Ministry of Industry Trade and Labor Foreign Trade Administration Investment Promotion Center Inspiration Invention Innovation Life Sciences in Israel www.investinisrael.gov.il Table of Contents Israel: A Powerhouse of Opportunities......................................... 2 Israel Life Science Sectors............................................................. 3 Medical Devices..........................................................................3 BioPharmaceutical...................................................................... 7 Israels Biomedical Engineering - Spotlight on Stem Cell Research......................................................1 1 Israels Life Sciences Competitive Edge....................................... 15 Government Support.................................................................. 19 2 Life Sciences in Israel Why Israel's Life Sciences More than 900 Life Sciences Companies - Biopharma and Israel: A Powerhouse of Opportunities Medical Devices Over a 1/3 of LS Start-Ups Over the last decade, Israel has introduced a wealth of groundbreaking already generate revenue and valuable innovations in Life Sciences. Israels Life Sciences sector is supported by a strong foundation of academic excellence, including Source of numerous some of the world's leading research institutes, renowned R&D facilities blockbuster drugs such as and cutting-edge medical centers. Bolstered by a highly skilled workforce, Copaxone and Rebif generating over $5B in annual a flourishing high-tech environment,
    [Show full text]
  • PROTALIX BIOTHERAPEUTICS, INC. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-33357 (Commission file number) PROTALIX BIOTHERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Florida 65-0643773 State or other jurisdiction (I.R.S. Employer of incorporation or organization Identification No.) 2 Snunit Street Science Park POB 455 Carmiel, Israel 20100 (Address of principal executive offices) (Zip Code) 972-4-988-9488 Registrant’s telephone number, including area code Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common stock, par value $0.001 per share NYSE MKT Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Ticker Name Sector Subgroup Market Cap Price P/E Gryld ESLT ELBIT SYSTEMS LTD Aerospace/Defense Aerospace/Defense-Equip 1872732
    Ticker Name Sector Subgroup Market Cap Price P/E GrYld ESLT ELBIT SYSTEMS LTD Aerospace/Defense Aerospace/Defense-Equip 1872732000 43.72 10.16 3.29 TATT TAT TECHNOLOGIES LTD Aerospace/Defense Aerospace/Defense-Equip 44163170 5.01 N/A N/A DELTY DELTA GALIL INDUSTRIES-ADR Apparel Apparel Manufacturers 132338700 5.65 N/A 6.01 CGEN COMPUGEN LTD Biotechnology Medical-Biomedical/Gene 142664900 4.16 N/A N/A PNTR POINTER TELOCATION LTD Commercial Services Commercial Services 19191250 4.01 11.46 N/A LAXAF LAXAI PHARMA LTD Commercial Services Research&Development 570408.8 0.01 N/A N/A BPHX BLUEPHOENIX SOLUTIONS LTD Computers Computer Services 15623440 0.63 N/A N/A JCDA JACADA LTD Computers Computer Services 9037805 2.25 N/A N/A TISA TOP IMAGE SYSTEMS LTD Computers Computers-Integrated Sys 17851280 2.00 18.18 N/A ELTK ELTEK LTD Electronics Circuit Boards 6940612 1.05 N/A N/A ELRNF ELRON ELECTRONIC INDS LTD Electronics Electronic Compo-Misc 122792500 4.14 N/A N/A RADA RADA ELECTRONIC INDS LTD Electronics Electronic Compo-Misc 19954930 2.25 12.50 N/A ORBK ORBOTECH LTD Electronics Electronic Measur Instr 444145500 10.31 7.26 N/A CAMT CAMTEK LTD Electronics Electronic Measur Instr 56486220 1.98 6.83 N/A ITRN ITURAN LOCATION AND CONTROL Electronics Electronic Secur Devices 258956200 12.35 N/A 8.10 MAGS MAGAL SECURITY SYS LTD Electronics Electronic Secur Devices 37967580 2.40 N/A N/A OTIV ON TRACK INNOVATIONS LTD Electronics Identification Sys/Dev 45468330 1.46 N/A N/A BSI ALON HOLDINGS BLUE SQ-ADR Food Food-Retail 342303500 5.19 N/A N/A WILC G.
    [Show full text]
  • Best Practices in Action
    best practices in action i ii best practices in action Guidelines for Implementing First-Class Business Incubation Programs REVISED 2ND EDITION BY Corinne Colbert, Dinah Adkins, Chuck Wolfe & Karl LaPan MCNAUGHTON & GUNN | SALINE, MICHIGAN NBIA gratefully acknowledges these sponsors who helped underwrite production of this book: iii Other Books Published by the National Business Incubation Association Speak Up! An Advocacy Toolkit for Business Incubators (PDF) Put It in Writing: Crafting Policies, Agreements, and Contracts for Your Incubator Measuring Your Business Incubator’s Economic Impact: A Toolkit (print and PDF) Incorporating Your Business Incubation Program: How Tax Status and Business Entity Affect Operations 2006 State of the Business Incubation Industry (print and PDF) Incubating in Rural Areas: Challenges and Keys to Success A Practical Guide to Business Incubator Marketing Technology Commercialization through New Company Developing a Business Incubation Program: Formation: Why U.S. Universities Are Incubating Companies Insights and Advice for Communities Incubating the Arts: Establishing a Program to Help Artists The Incubation Edge: How Incubator Quality and Regional and Arts Organizations Become Viable Businesses Capacity Affect Technology Company Performance Bricks & Mortar: Renovating or Building a Business A Comprehensive Guide to Business Incubation, Completely Incubation Facility (PDF) Revised 2nd Edition Human Resources: Finding the Right Staff for Your Incubator Incubation in Evolution: Strategies and Lessons Learned in Four Countries (print and PDF) Business Incubation Works Self-Evaluation Workbook for Business Incubators The Art & Craft of Technology Business Incubation: Best Practices, Strategies, and Tools from More Than 50 Programs Incubating Technology Businesses: A National Benchmarking Study Find these titles and others at www.nbia.org/store.
    [Show full text]
  • Investing in Israel
    FOREWORD BlueStar Global Investors develops investment solutions and research on Israeli and Middle Eastern/Mediterranean markets and economies. This is a September 2014 update of our inaugural “BluePaper,” originally published in February 2014, on a topic that is highly relevant to prospective investors in Israeli equities. IWeNVESTING contrast the perception of risk IN ISRAEL in Israeli markets versus the reality of economic resilienceThe and Impact correlations of with Geopolitical Risk global rather than local events. Our conclusion supports an allocation to Israeli equities based not on emotions, but on Updated September 2014: empirical performance. Including analysis of Operation Protective Edge FOREWORD BlueStar Global Investors develops investment solutions and research on Israeli and Middle Eastern/Mediterranean markets and economies. This is an updated version of our inaugural “BluePaper,” originally published in February 2014, on a topic that is highly relevant to prospective investors in Israeli equities. We contrast the perception of risk in Israeli markets versus the reality of economic resilience and correlations with global rather than local events. Our conclusion supports an allocation to Israeli equities based not on emotions, but on empirical data and economic performance. Joshua Kaplan Research Analyst Bruce Schoenfeld Director of Research Steven A. Schoenfeld Chief Investment Officer INTRODUCTION stream of terrorist attacks from both outside and within its borders. Conventional wisdom suggests that living in a dangerous neighborhood can negatively impact your finances. High-risk areas may result in lower property values and higher insurance premiums. Following the same logic, one might assume that the residents in a rough neighborhood would be more likely to cower in their homes than to venture out and help build a vibrant, innovative local economy.
    [Show full text]
  • Len Rosen Joins Evercore As Senior Managing Director and CEO of the Firm’S New Business in Israel
    Len Rosen Joins Evercore as Senior Managing Director and CEO of the Firm’s New Business in Israel NEW YORK, September 24, 2019 – Evercore (NYSE: EVR) announced today that Len Rosen has joined the Firm as a Senior Managing Director and CEO of the Firm’s new business in Israel. He will be based in Tel Aviv. Mr. Rosen was most recently the CEO of Barclays Israel, and before that held the same position at Lehman Brothers. Over the course of his 25-year career as a trusted advisor to clients in Israel, he has advised clients on many of the largest and most important M&A transactions, including Orbotech’s sale to KLA, Orbotech’s acquisitions of Photon Dynamics and Frontline, Given Imaging’s sale to Covidien, Verint’s acquisition of Witness Systems, SuperDerivatives’ sale to ICE Noble Energy’s sale of a stake in the Tamar natural gas field and a number of acquisitions for Teva Pharmaceuticals. In addition, Mr. Rosen has been involved in over 100 IPOs and equity transactions, including the IPOs of Ormat Geothermal, Verint, Mobileye, CyberArk, ADO Properties, ReWalk, Foamix, Kornit and Caesarstone. He has also been involved in over 60 fixed income transactions for Israel and Israeli companies, including the sovereign, Israel Electric and the emerging Israeli companies in the natural gas sector. John Weinberg, Evercore’s Executive Chairman, said, “Israel has one of the most important ecosystems for technology and innovation globally, making it an extremely attractive environment for our advisory business. Len’s strong relationships and extensive experience will enable us to provide best in class service to clients in Israel on their important strategic and financial issues, and we are pleased that he will be leading our business there.” Ralph Schlosstein, Evercore’s President and CEO, said, “Len has a great reputation as the pre- eminent investment banker in Israel, with a long and successful track record of advising clients on landmark Israeli transactions.
    [Show full text]
  • Opko Health: the Placebo Effect
    Opko Health: The Placebo Effect Lakewood Capital Management December 2013 /placebo effect/ (plah-se’bo ĕ-fekt’), noun [L.]: 1. the beneficial effect that occurs following a treatment administered to a group that arises simply from that group’s faith or preconceptions that the treatment will work. 2. an ineffectual treatment intended to deceive the recipient. Table of Contents A.) Executive Summary ................................................................................................... 1 B.) A Dizzying History Of Deals and Disappointment .................................................. 8 C.) Poor Financial Results… Yet A Soaring Market Capitalization ............................. 15 D.) Latin American Drug Distribution ........................................................................... 17 E.) Exploratory Alzheimer’s Diagnostic ...................................................................... 18 F.) Claros Diagnostics ................................................................................................... 19 G.) 4Kscore™ Exploratory Prostate Cancer Screening Test ......................................... 22 H.) Rayaldy .................................................................................................................... 26 I.) Prolor Biotech .......................................................................................................... 30 J.) A Web Of Stock Promotion ..................................................................................... 33 K.) Insider Share Purchases
    [Show full text]
  • Signature Redacted
    VC Funding Elements in US-Israel Case and Application to China-Korea By Anna Lee B.S. Business Administration, Finance and Corporate Management California State University, East Bay, 2012 SUBMITTED TO THE MIT SLOAN SCHOOL OF MANAGEMENT IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN MANAGEMENT STUDIES AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY JUNE 2017 @2017 Anna Lee. All rights reserved. The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created. Signature redacted Signature of Author: V MIT Sloan S chool of Management May 12, 2017 Signature redacted Certified by: Jake Cohen Seniot Associate Dean for Undergraduate and Master's Programs Thesis Supervisor Signature redacted Accepted by: MASSA H IsENSTITUTE Rodrigo Verdi OFTEHNLGY Associate Professor of Accounting JUN 2 0 2017 Program Director, M.S. in Management Studies Program LIBRARIES ARCHIVES 77 Massachusetts Avenue Cambridge, MA 02139 MITLibraries http://Iibraries.mit.edu/ask DISCLAIMER NOTICE Due to the condition of the original material, there are unavoidable flaws in this reproduction. We have made every effort possible to provide you with the best copy available. Thank you. The images contained in this document are of the best quality available. Th c ppo n K> 2 VC Funding Elements in US-Israel Case and Application to China-Korea By Anna Lee Submitted to MIT Sloan School of Management on May 12, 2017 in Partial Fulfillment of the requirements for the Degree of Master of Science in Management Studies.
    [Show full text]
  • Corporate Clients of Compliance Training Online®
    Corporate Clients of Compliance Training Online® 'Round The Clock Service Inc Knox Excavating LLC 0906454 British Columbia Ltd Knudsen Construction 1st Choice Aerospace Knutsen Dental Solutions 1st National Bank KO Construction 1 Stop Pool Pros Inc Koalatech Restoration 1 Sun Solar Electric KOARTAN Microelectronic Interconnect Materials 1-855-Fix-Light Koasati Construction Management 10 Federal Kobus Construction USA Inc 10 Tanker Air Carrier LLC Koch Logistics 15 Lightyears Inc Koch-Gitsch Canada LP 10000 Lakes Archaeology Inc Kocharian Company 100 Kocsis Scaffolding Systems 101 Industries Ltd KODA Care 1010 Kodak Polychrome Graphics 101083514 Sk Ltd Kodiak Carbonic LLC 1027622 AB LTD Kodiak Environmental Contracting LLC 1071 Industries LLC Kodiak Steel 11 Bravo Restoration Kodru Equipment 123 Engineering Inc Koeppel Nissan 1258995 Alberta Ltd Koffler Electrical Mechanical 126959 Alberta Ltd KOGAP Enterprises Inc 1339352 Alberta Ltd Koh Young Technology Inc 1592118 Alberta Ltd Koham LLC 1668422 Alberta Ltd Koi Tattoo 1669753 Alberta Ltd Kolb Electric 16x9 Inc Kolb Grading LLC 1736394 Alberta Ltd KO Manufacturing Inc 18 Karat Inc Komline-Sanderson 1 1841843 Alberta Ltd KONE Corporation 1849440 Alberta Ltd Kone Elevator Company 1991 Konecranes 1993 Kongsberg Automotive 1st Business Solutions Konopka Electric LLC 1st Class Home Inspection Konwinski Construction 1st Freight KOO Construction 1st In Fire & Safety LLC Kooima Company 2Brothers Contracting LLC Koontz Electric 2 Griffins Inc Koopman Roofing 2 H&V CONSTRUCTION Kope Logistics 2-Way Communications
    [Show full text]